MBMichael R. Betts

Michael R. Betts

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael R. Betts has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Smed-Sorensen

    Center for Infectious Medicine, Karolinska Institute , Stockholm

    1 shared publication
  • Daniel C. Douek

    Human Immunology Section, National Institutes of Health , Bethesda, MD 20892

    1 shared publication
  • David Anthony Price

    Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK

    1 shared publication
  • David R. Ambrozak

    Immunology Laboratory, National Institutes of Health , Bethesda, MD 20892

    1 shared publication
  • F. Javier Guenaga

    Human Immunology Section, National Institutes of Health , Bethesda, MD 20892

    1 shared publication
  • Jason M. Brenchley

    Human Immunology Section, National Institutes of Health , Bethesda, MD 20892

    1 shared publication

Latest Publications

  • Open Access

    The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration

    by Michael R. Betts, David A Price, Jason M. Brenchley, Karin Loré, F. Javier Guenaga, Anna Smed-Sorensen, David R. Ambrozak, Stephen A Migueles, Mark Connors, Mario Roederer, et al.

    Antiviral CD8+ T cells can elaborate at least two effector functions, cytokine production and cytotoxicity. Which effector function is elaborated can determine whether the CD8+ T cell response is primarily inflammatory (cytokine producing) or antiviral (cytotoxic). In this study we demonstrate that cytotoxicity can be triggered at peptide concentrations 10- to 100-fold less than those required for cytokine production in primary HIV- and CMV-specific human CD8+ T cells. Cytolytic granule exocytosis occurs at peptide concentrations insufficient to cause substantial TCR down-regulation, providing a mechanism by which a CD8+ T cell could engage and lyse multiple target cells. TCR sequence analysis of virus-specific cells shows that individual T cell clones can degranulate or degranulate and produce cytokine depending on the Ag concentration, indicating that response heterogeneity exists within individual CD8+ T cell clonotypes. Thus, antiviral CD8+ T cell effector function is determined primarily by Ag concentration and is not an inherent characteristic of a virus-specific CD8+ T cell clonotype or the virus to which the response is generated. The inherent ability of viruses to induce high or low Ag states may be the primary determinant of the cytokine vs cytolytic nature of the virus-specific CD8+ T cell response.